Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)
Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)
CAS No. 429619-37-4
Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)( ——— )
Catalog No. M40406 CAS No. 429619-37-4
Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)
-
DescriptionPhe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number429619-37-4
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rosthornin B
Rosthornin B is a kind of natural product derived from the herbs of Rabdosia rosthornii.
-
Protopine hydrochlor...
Protopine has antiplatelet effects,which is due to inhibition on thromboxane formation and phosphoinositides breakdown and then lead to the decrease of intracellular calcium concentration.
-
Tinurilimab
Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.
